• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Open Forum Infect Dis . Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients

tetano

Editor, Senior Moderator
Open Forum Infect Dis


. 2022 Oct 31;9(11):ofac585.
doi: 10.1093/ofid/ofac585. eCollection 2022 Nov.
Immune Senescence Markers Predict the Cellular Immune Response to BNT162b2 Vaccination in Hemodialysis Patients


Jens T Van Praet[SUP] 1 2 [/SUP], Marie De Groote[SUP] 3 [/SUP], Dirk De Bacquer[SUP] 4 [/SUP], Ellen Verhalleman[SUP] 5 [/SUP], Ziggy Welvaert[SUP] 5 [/SUP], Jan Emmerechts[SUP] 6 [/SUP], Marijke Reynders[SUP] 7 [/SUP], An S De Vriese[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Chronic kidney disease is associated with increased risk of frailty and accelerated immune senescence, potentially affecting the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.
Methods: Humoral and cellular responses against the spike protein of SARS-CoV-2 were determined in 189 COVID-naive hemodialysis patients at week 4 and 8 after vaccination with 2 doses of BNT162b2. Frailty indicators and immune senescence markers were determined at baseline to identify predictors of the immune response.
Results: Controlling for age, activities of daily living (ADLs), instrumental ADLs, walking pace, and the clinical frailty score correlated negatively and hand grip strength positively with the humoral response. Controlling for age, the proportions of memory CD4[SUP]+[/SUP] T cells, memory CD8[SUP]+[/SUP] T cells, CD28[SUP]null[/SUP] T cells, and CD57[SUP]+[/SUP]CD8[SUP]+[/SUP] T cells correlated negatively with the humoral response, whereas the proportions of memory CD4[SUP]+[/SUP] T cells and CD28[SUP]null[/SUP] T cells correlated negatively and the CD4/CD8 ratio positively with the cellular response. In a multivariate model, only the proportions of memory CD4[SUP]+[/SUP] T cells and CD28[SUP]null[/SUP] T cells independently predicted the cellular response.
Conclusions: Markers of immune senescence, but not frailty indicators, independently predict the cellular immune response after vaccination in hemodialysis patients, overruling the effect of chronological age.

Keywords: BNT162b2 vaccination; COVID-19; SARS-CoV-2; frailty; hemodialysis; immune response; immune senescence.
 
Back
Top Bottom